Skip to content

Clinical trials

Phase 2 COVID-19 trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: COVID-19 Phase: Phase 2 Country / region: Germany Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20181
202011
202110
20225

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Terminated9
Unknown status3
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
BioNTech SE3
Charite University, Berlin, Germany2
University Hospital Tuebingen2
Apeiron Biologics1
AstraZeneca1
Atriva Therapeutics GmbH1
Basilea Pharmaceutica1
Carsten Müller-Tidow1
Charité Research Organisation GmbH1
Deutsches Rotes Kreuz DRK-Blutspendedienst Baden-Wurttemberg-Hessen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
COVID-1927
Coronavirus Infections2
Severe Acute Respiratory Syndrome2
Acute Lung Injury1
Anemia, Sickle Cell1
Aspergillosis1
Disease1
Invasive Fungal Infections1
Lymphoma, Follicular1
Mycoses1

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.